Do you want to read an article? Please log in or register.
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Radio-Oncology
Related content
Radio-Oncology
Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at Diagnosis
Cancers (Basel)
Kinj R, Hottinger AF, Böhlen TT, Ozsahin M, Vallet V, Dunet V, Bouchaab H, Peters S, Tuleasca C, Bourhis J, Schiappacasse L
doi: 10.3390/cancers16091742
Lung, Respiratory and Thoracic Cancer
Dosiomics and radiomics-based prediction of pneumonitis after radiotherapy and immune checkpoint inhibition: The relevance of fractionation
Lung Cancer
Kraus KM, Oreshko M, Schnabel JA, Bernhardt D, Combs SE, Peeken JC
doi: 10.1016/j.lungcan.2024.107507
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
Lung Cancer
Tozuka T, Noro R, Mizutani H, Kurimoto F, Hakozaki T, Hisakane K, Naito T, Takahashi S, Taniuchi N, Yajima C, Hosomi Y, Hirose T, Minegishi Y, Okano T, Kamio K, Yamaguchi T, Seike M, East Japan Chesters Group
doi: 10.1016/j.lungcan.2024.107540
Genitourinary Cancer
Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis
Prostate Cancer Prostatic Dis
Creta M, Shariat SF, Marra G, Gontero P, Rossanese M, Morra S, Teoh J, Kishan AU, Karnes RJ, Longo N
doi: 10.1038/s41391-024-00883-3
Central Nervous System Tumors
Predicting the risk of neurocognitive decline after brain irradiation in adult patients with a primary brain tumor
Neuro Oncol
Tohidinezhad F, Zegers CML, Vaassen F, Dijkstra J, Anten M, Van Elmpt W, De Ruysscher D, Dekker A, Eekers DBP, Traverso A
doi: 10.1093/neuonc/noae035
ESMO 2024
Breast Cancer
DESTINY-Breast12: T-DXd proved effective in patients with HER2-positive metastatic breast cancer with or without brain metastases
ESMO 2024
Lung, Respiratory and Thoracic Cancer
TROPION-Lung01: Dato-DXd benefits patients with advanced non-squamous NSCLC with or without brain metastases
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [(18)F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Oncol
Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, Hapdey S, Kolesnikov-Gauthier H, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boissellier P, Guillemard S, Salem N, Brenot-Rossi I, Le Péchoux C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Moisson P, Larrouy A, Modzelewski R, Gouel P, Ghazzar N, Langlais A, Amour E, Zalcman G, Giraud P
doi: 10.1016/S1470-2045(24)00320-6
Radio-Oncology
Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis
Int J Cancer
Ehret F, Rueß D, Blanck O, Fichte S, Chatzikonstantinou G, Wolff R, Mose L, Mose S, Fortmann T, Lehrke R, Turna M, Caglar HB, Mortasawi F, Bleif M, Krug D, Ruge MI, Fürweger C, Muacevic A
doi: 10.1002/ijc.34980